- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Beta Drugs Limited — Updates, 10-01-2026: General Updates
10-01-2026 | 06:45 pm
10-01-2026 | 06:45 pm
Beta Drugs is acquiring a 66.09% stake in Nivian Lifesciences for INR 69.4 Cr, valuing Nivian at INR 105 Cr. This strategic move establishes Beta in the fast-growing IVF therapy market, enhancing its branded formulations portfolio. Nivian's sales are estimated at ~INR 43 Cr.
No comments yet. Be the first to comment!